DUBLIN, Ireland--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced the results from its Annual General Meeting. Five proposals were on the meeting agenda:
- Receipt and consideration of the Irish Statutory Accounts for the fiscal year ended September 25, 2009, and the reports of the Directors and Auditors thereon
- Election of Directors
- Appointment of Independent Auditors
- Authorization of the Company and/or any subsidiary of the Company to make market purchases of Company shares, and
- Authorization of the reissue price range of treasury shares.
At the meeting, shareholders received the Irish Statutory Accounts and related reports and elected all 11 nominees, each of whom currently serves on Covidien’s Board of Directors. They are: Craig Arnold, Robert H. Brust, John M. Connors, Jr., Christopher J. Coughlin, Timothy M. Donahue, Kathy J. Herbert, Randall J. Hogan, III, Richard J. Meelia, Dennis H. Reilley, Tadataka Yamada, and Joseph A. Zaccagnino.
Shareholders also approved the appointment of Deloitte & Touche LLP to serve as the Company’s independent auditors, authorized the Company to make market purchases of Company shares and authorized the reissue price range for treasury shares.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2009 revenue of $10.7 billion, Covidien has 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.
Contacts
Covidien plc
Eric Kraus, 508-261-8305
Senior Vice President
Corporate Communications
eric.kraus@covidien.com
or
Coleman Lannum, 508-452-4343
CFA
Vice President
Investor Relations
cole.lannum@covidien.com
or
Bruce Farmer, 508-452-4372
Vice President
Public Relations
bruce.farmer@covidien.com
or
Brian Nameth, 508-452-4363
Director
Investor Relations
brian.nameth@covidien.com